US States Enact E-Cigarette Bans, PMTA Registry Bills Trigger Controversy

Regulations by 2FIRSTS, edited by Sophia
May.06.2024
US States Enact E-Cigarette Bans, PMTA Registry Bills Trigger Controversy
Virginia bans flavored e-cigarettes, Iowa still undecided. Critics argue laws harm smoking cessation options. Major economic impact expected.

According to overseas media FilterMag, on May 2nd, it was reported that flavored e-cigarettes will be banned in the state of Virginia, but the ban will not take effect until one year later. Meanwhile, the decision on similar legislation in Iowa is pending the governor's signature or veto. These are just the latest PMTA registration laws, which are increasingly spreading across the United States under the guise of protecting consumers from unregulated products. Critics argue that these laws harmfully restrict people's options for quitting smoking.

 

Iowa Governor Kim Reynolds has not indicated whether she will sign a bill passed by the legislature in April. The Consumer Advocates for Smoke-free Alternatives Association (CASAA) has dubbed it the "Big Tobacco Protection Act." In Virginia, lawmakers also recently passed a registration bill, which Governor Glenn Youngkin (R) approved but with an amendment to delay implementation until July 1, 2025. The bill was passed by the legislature in April.

 

Oklahoma, Louisiana, and Alabama have implemented the PMTA registration legislation, according to Ecigator reports. While laws in Kentucky, Utah, and Wisconsin are set to take effect by 2025 (though there is ongoing litigation against the legislation in Kentucky), a report states that "legislators in about 20 other states are currently considering similar bills.)

 

According to advocates for harm reduction in tobacco, banning flavored e-cigarettes will only lead consumers to turn to the illegal market or even revert back to traditional cigarettes. Research also indicates that the choice of flavors is highly important for individuals transitioning from cigarettes to e-cigarettes.

 

However, tobacco companies that are actively promoting the above-mentioned legislation have a different perspective on this. They believe that these laws will help combat the illicit tobacco market and ensure that all kinds of businesses accept products authorized by the U.S. Food and Drug Administration (FDA).

 

Critics of these bills argue that small businesses and individuals trying to quit smoking will suffer. More than 1,800 people in Virginia could lose their jobs, and the state could lose over $250 million in economic benefits. Small businesses will also face fines of $1,000 per day for each unapproved product they sell. While tobacco giants are advocating for the ban, the public is skeptical of their motives.

 

Most legislators do not understand that the purpose of the PMTA registration is to ban the sale of the majority of e-cigarette products intended for use by adults in this state.

 

The FDA is facing harsh criticism from tobacco harm reduction advocates for denying millions of PMTA applications. They argue that the barriers to submission are so high that only the largest companies with significant financial and scientific resources have a chance at authorization.

 

However, one of the sponsors of the legislation, Virginia Delegate Rodney Willett (D-Henrico), said that despite the lengthy challenge, the FDA's program is important because a large number of e-cigarette products from China are flooding in, which he referred to as being "largely unregulated and untaxed in most cases." Willett believes, "Most legislators do not understand that the purpose of PMTA registration is to ban the sale of the vast majority of e-cigarette products used by adults in this state." "They think they are fighting against villains from China, but in reality, they are making the lives of their own constituents worse."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | Full-screen display and 10K puffs: IVG launches new Pro-series pod vape in the UK
Product | Full-screen display and 10K puffs: IVG launches new Pro-series pod vape in the UK
E-cigarette brand IVG has recently rolled out the IVG Pro 2 across several UK online retailers. The device is compatible with IVG Pro pods and comes in 33 flavours with nicotine strengths of 0mg, 10mg and 20mg. Channel listings show a 2ml prefilled pod paired with a 10ml refill container, with pricing around £9.99.
Feb.02 by 2FIRSTS.ai
Multi-agency crackdown targets vape and convenience stores across Wirral, seizing illegal cigarettes and non-compliant pods
Multi-agency crackdown targets vape and convenience stores across Wirral, seizing illegal cigarettes and non-compliant pods
A multi-agency, intelligence-led enforcement operation took place on January 27, 2026, targeting vape and convenience stores across Wirral, including West Kirby, to disrupt the supply of illegal tobacco and vaping products. Six premises were inspected, with approximately 10,500 illegal cigarettes seized along with vape pods that were not in original packaging or did not meet UK regulatory requirements.
Feb.05 by 2FIRSTS.ai
Product | OXVA launches SlimStick X in Europe and the U.S., shifting from pre-filled to open-system refilling
Product | OXVA launches SlimStick X in Europe and the U.S., shifting from pre-filled to open-system refilling
OXVA has recently launched its new e-cigarette, the SlimStick X. Unlike its predecessor, the SlimStick, which used a pre-filled pod system, the SlimStick X adopts an open-system refillable design, featuring a 2ml pod, a 1.0Ω coil, and a 1400mAh battery. The product has entered online retail channels in markets including the United States, the United Kingdom, Greece, and Spain, with a price of about $23.99.
Mar.06 by 2FIRSTS.ai
3,200 suspected "drug-laced cigarettes" seized in Johor Bahru, case value estimated at US$242,500
3,200 suspected "drug-laced cigarettes" seized in Johor Bahru, case value estimated at US$242,500
Malaysian police seized 3,200 suspicious e-pods with ketamine liquid, arresting two men in Johor Bahru's drug distribution bust.
Feb.04 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
2Firsts Interview | Prague Move Puts Eastern Europe in Focus for Nicotine Industry Event EVO NXT
2Firsts Interview | Prague Move Puts Eastern Europe in Focus for Nicotine Industry Event EVO NXT
EVO NXT will move to Prague in April 2026. As an event’s official media partner for four consecutive years, 2Firsts recently interviewed the organisers, who said the relocation reflects strong growth in Eastern European markets for alternative nicotine products. They described EVO NXT as not a traditional trade fair but a business festival shaped by rapid changes in regulation, markets and technological innovation across the global nicotine industry.
Feb.03